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Purpose: To identify factors associatedwith an increased risk of fractures in Long-Gap Esophageal Atresia (LGEA)
patients. Following implementation of a risk-stratiﬁed program, we hypothesized a reduction in fracture inci-
dence within this potentially high-risk population.
Methods: A retrospective review of LGEA-patients admitted between 2005 and 2014 was conducted. Symptom-
atic fractures with radiographic conﬁrmation were deﬁned as events. Univariate andmultivariable analysis eval-
uated factors including admission weight-for-age z-score, primary versus secondary Foker process (FP), weight
at Foker Stage I, days and episodes of paralysis, number of parenteral nutrition (PN) days, cumulative dose of loop
diuretics adjusted for body weight and days exposed, and exposure to non-loop diuretics. A fracture-prevention
protocol was initiated in 2012; incidence was evaluated pre and post-intervention.
Results: Fifty-nine patients met inclusion criteria. Twenty-three (39%) patients in the entire cohort incurred at
least one fracture during their hospitalization utilizing the Foker process. Given this high percentage, a targeted
fracture-prevention protocol was initiated in 2012. Fracture incidence decreased from 48% prior to the protocol
to 21% following the protocol (P= 0.046). Several variables that were associated with an increased risk of frac-
tures on univariate analysis included prior esophageal anastomosis attempt (P=0.008), number of separate ep-
isodes of paralysis (P = 0.002), exposure to non-loop diuretics (P = 0.006), cumulative loop diuretic dose
(P b 0.001), as well as cumulative loop diuretic over days exposed (P b 0.001). Intensive care unit (ICU) stay
(P = 0.002) and total length of hospitalization (P b 0.001) were also signiﬁcantly longer among patients with
a fracture. Number of separate episodes of paralysis was the only independent risk factor for the development
of a fracture; patients havingmore than 3 episodes of paralysis had an estimated risk of fracture 15 times higher
than those patients paralyzed only once or twice (O.R. 15.87, 95% C.I.: 1.47–171.23, P= 0.008).
Conclusion:Episodes of paralysis appeared to be themost signiﬁcant risk factor for fractures in patientswith LGEA
who underwent the Foker procedure. The incidence of symptomatic fractures decreased signiﬁcantly following
implementation of a standardized protocol in this series of LGEA patients with continued prospective evaluation.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).conﬂicts of interest or funding
and Pediatric Surgical Research
of Surgery, 2150 Pennsylvania
-B, Washington DC 20037 and
urgery, Fegan, 3rd Floor, 300
. This is an open access article under1. Introduction
Long-Gap Esophageal Atresia (LGEA) is a rare congenital anomaly
and frequently requires utilization of interventions that may expose in-
fant patients to increased fracture risk (David and O'Callaghan, 1975;
Bairdain et al., 2014, In Press). LGEA is often deﬁned by a distance be-
tween the upper and a lower atretic esophageal segment of greater
than three vertebral bodies (Gross, 1953; Foker et al., 1997). This dis-
tance ultimately delineates the timing and ease of repair. Foker et al.the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Table 1
Univariate analysis of LGEA patients & possible risk factors associated with fracture.
Variable Fracture
(n = 23)
No fracture
(n = 36)
P value
Gender 0.60
Male 13 (43%) 17 (57%)
Female 10 (35%) 19 (65%)
Birth weight (kg) 2.5 ± 0.8 2.5 ± 0.8 0.83
Weight for age Z-score (WAZ) −1.6 ± 1.8 −1.4 ± 1.6 0.65
Preoperative gap length (cm) 4.9 ± 1.9 4.4 ± 1.1 0.28
Type of LGEA 0.008⁎
Primary 7 (23%) 24 (77%)
Secondary 16 (57%) 12 (43%)
Age at Foker I (months) 5 (3–9) 3 (2–5) 0.17
Number of PN days 39 (21–77) 32 (22–47) 0.20
Number of times paralyzed 2 (1–5) 1 (1–1) 0.002⁎
Episodes of paralysis b0.001⁎
1–3 12 (25%) 35 (75%)
N3 11 (92%) 1 (8%)
Loop diuretic exposure (days) 41 (17–129) 11 (5–15) b0.001⁎
Cum. loop diuretic equivalent
(E/kg)
55.1
(21.5–404.8)
12.0 (4.1–17.6) b0.001⁎
Cum. loop diuretic equivalent
(E/kg/days)
1.38 (1.20–2.62) 1.07
(0.96–1.31)
b0.001⁎
Exposure to non-loop diuretic 0.006⁎
Yes 9 (27%) 24 (73%)
No 14 (67%) 7 (33%)
Fracture protocol exposure 0.046⁎
Yes 4 (21%) 15 (79%)
No 19 (48%) 21 (52%)
LGEA: Long-Gap Esophageal Atresia; PN: parenteral nutrition; ICU: intensive care unit;
LOS: length of stay. Continuous data aremean± standarddeviation ormedian (interquar-
tile range).
⁎ Statistically signiﬁcant association.
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sutures to promote in vivo growth of the esophagus through tension-
induced natural lengthening followed by delayed primary repair
(Foker et al., 1997). During this Foker process, patients typically re-
quired prolongedmechanical ventilation, pharmacological paralysis, se-
dation and analgesia, and utilization of central venous catheters (CVCs)
to facilitate medication and parenteral nutrition (PN) administration
(Bairdain et al., 2014). The degree and length of exposure to these afore-
mentioned entities is proportional to the difﬁculty of the repair. As a
referral center for LGEA, Boston Children's Hospital (BCH) provides a
unique environment to evaluate the potential effects of exposure to cer-
tain interventions and the development of inpatient fractures (Bairdain
et al., In Press). Therefore, we aimed to identify factors associated with
increased risk of fractures in LGEA patients undergoing the Foker pro-
cess. Following implementation of a risk-stratiﬁed fracture prevention
program, we also hypothesized that there would be a reduction in frac-
ture incidence within this high-risk population.
2. Methods and materials
2.1. Population and deﬁnitions
Following the approval of our institutional review board (IRB), we
retrospectively reviewed the medical records of all patients managed
utilizing the Foker process for LGEA from2005 to 2014 at our institution.
Esophageal atresia (EA) patients with orwithout tracheoesophagealﬁs-
tula (TEF) were considered to have LGEA when primary anastomosis
was not possible because of length of the gap between the upper and
lower esophageal segments (Al-Shanafey and Harvey, 2008). All other
forms of EA as well as those who did not undergo the Foker process
(FP) were excluded. Primary LGEA patients were those patients who
did not undergo a previous operation or whose previous operations
were limited to a gastrostomy placement while those patients who
had esophageal surgery elsewhere were considered secondary FP
cases (Bairdain et al., In Press).
During the FP, patients were intubated, sedated and muscle relaxed
during external traction. Patient received parental nutrition (PN) while
they were nil per os (NPO). There was not a standardized regimen for
when and what types of diuretics were utilized; this treatment was at
the discretion of the treatment team. We categorized diuretics into
loop and non-loop diuretics groups. We determined use of non-loop di-
uretics as a dichotomous variable based on any versus no use. Since loop
diuretic use was more common and has a greater association with frac-
tures, we normalized the comparative doses of the various loop di-
uretics. The approximate dose equivalency used for this evaluation
was bumetanide 1 milligram (mg) = furosemide 40 mg = torsemide
20 mg= ethacrynic acid 50 mg (Lexicomp).
Symptomatic fractures were deﬁned as incident events when ra-
diographic assessment and conﬁrmation of fracture was prompted
by identiﬁcation of unilateral swelling and/or limited range of motion
of the affected limb, as well as those which raised clinical concern by
healthcare providers prompting diagnostic imaging. Routine screening
imaging for identiﬁcation of non-symptomatic fractures was not con-
ducted. LGEA patients who developed a symptomatic fracture were
compared to those LGEA patients who did not develop a fracture.
2.2. Fracture protocol initiatives
A fracture-prevention protocol was initiated in 2012; incidence of
fractureswas evaluated pre and post-intervention. The fracture preven-
tion protocol focused on the following initiatives: limiting medications
detrimental to bone health; repleting Vitamin D both before and after
paralysis; optimizing nutrients and minerals such as calcium and
phosphorus in PN and in feeds; weekly labs during and after paralysis;
multiple daily sessions with physical therapy (PT) for passive range of
motion; educating family and care team about careful handling andfracture risk, and, instituting hospital-wide fracture precaution guide-
lines for during and after paralysis.
2.3. Statistical analysis
Variableswere evaluated as potential risk factors for development of
a fracture. Univariate analysis evaluated factors including gender, birth
weight, preoperative gap length (cm), admission weight-for-age Z-
score (WAZ), primary versus secondary Foker process (FP) patients,
weight at Foker Stage I, days and episodes of paralysis, number of PN
days, cumulative dose of loop diuretics adjusted for body weight and
days exposed, and exposure to non-loop diuretics. Five covariates
were further tested by multivariate logistic regression including: type
of LGEA (Primary versus Secondary); number of unique episodes of pa-
ralysis; cumulative exposure to loop diuretics (furosemide equivalents/
kg/day); exposure to non-loop diuretics; and exposure to fracture
reduction protocol. Independent risk factors for the development of
fractures were identiﬁed by the likelihood ratio test in multivariable lo-
gistic regression analysis with odds ratios and 95% conﬁdence intervals
(Hosmer et al., 2013). Statistical analysis was performed using IBMSPSS
Statistics (version 21.0, IBM, Armonk, NY). Continuous data aremean±
standard deviation (SD) or median and interquartile range, and multi-
variate logistic regression was utilized to identify independent predic-
tors of fracture (Vittinghoff and McCulloch, 2007). Two-tailed values
of P b 0.05 were considered statistically signiﬁcant.
3. Results
Fifty-nine patients met inclusion criteria and were included in the
study. Twenty-three (39%) patients in the entire cohort incurred at
least one fracture during the hospitalization utilizing the Foker process.
This included 11 patients who suffered fractures to the humerus, 6 pa-
tients who suffered fractures to the femur, and 6 patients who suffered
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Fig. 1. This ﬁgure illustrates the change in the incidence of symptomatic fractures among
patients with Long-Gap Esophageal Atresia; it decreased signiﬁcantly following imple-
mentation of a standardized protocol. This ﬁgure also denotes that the main risk factor
for fractureswas episodes of paralysis. Thosewho underwent 3 ormore paralysis episodes
during their Foker process had the highest risk for fracture.
3S. Bairdain et al. / Bone Reports 3 (2015) 1–4both. Given this high percentage in a speciﬁc population, a targeted
fracture-prevention protocol was initiated in 2012. Fracture incidence
decreased from 48% prior to the protocol to 21% following the protocol
(P= 0.046) (see Table 1).
Baseline characteristics such as gender, birth weight, preoperative
gap length, age at Foker process and exposure to PN were not risk fac-
tors in our cohort of patients for fractures. Univariate analysis identiﬁed
several variables that increased risk for fractures, including secondary-
FP patients (P = 0.008), number of paralytic episodes (P = 0.002),
exposure to non-loop diuretics (P = 0.006), cumulative loop diuretic
dose (P b 0.001), as well as cumulative loop diuretic over days exposed
(P b 0.001). Outcomemeasures such as intensive care unit and total hos-
pital stay (P b 0.001)were also signiﬁcantly longer among patients with
a fracture. Median ICU length of stay was 111 days (range: 73–
217 days) in those with a fracture versus 62 days (range: 37–
110 days) without a fracture (P= 0.002). Median total hospital length
of staywas 155days (range: 111–240 days) in thosewith a fracture ver-
sus 93 days (range: 63–147 days) (P b 0.001).
Five covariates were tested by multivariable logistic regression
analysis. This included the type of LGEA (Primary versus Secondary);
number of unique episodes of paralysis; cumulative exposure to loop
diuretics (furosemide equivalents/kg/day); exposure to non-loop di-
uretics; and exposure to fracture protocol. Table 2 conﬁrmed that the
number of times paralyzed was the only independent risk factor for
the development of a fracture; patients with more than 3 unique epi-
sodes of paralysis incurred an estimated risk of fracture over 15 times
higher than those patients paralyzed only once or twice (OR 15.87,
95% CI: 1.47–171.23, P=0.008) (see Fig. 1). Multivariable analysis indi-
cated that type of LGEA (P=0.87), cumulative loop diuretic equivalent
exposure (P=0.29), exposure to non-loop diuretics (P=0.38), and ex-
posure to fracture protocol (P=0.70)were not signiﬁcant independent
risk factors associated with the development of a fracture as seen in
Table 2.
4. Discussion
Bone health has not previously beenwell-described in patients with
LGEA. We identiﬁed a signiﬁcant incidence of fractures in our cohort of
infants with LGEAwho underwent the Foker process. Multiple episodes
of paralysis was the primary factor associated with highest risk of frac-
tures in our cohort, albeit the small number of cases overall. The speciﬁc
etiology of fractures in each individual LGEA patient remains unknown;
however, the three major factors that likely contributed were:
(a) prolonged immobilization due to pharmacological muscle relaxa-
tion, (b) suboptimal nutritional status due to need for parenteral nutri-
tion, and (c) relatively high utilization of diuretics. Speciﬁc targeted
interventions seemed to signiﬁcantly decrease incidence of fractures
in this high-risk population including optimizing nutritional status
prior to initiating and during the Foker process, utilizing fracture pre-
cautions and incorporating PT while paralyzed, and limiting medica-
tions detrimental to bone health.
Given that our sample sizewas smaller following implementation of
a risk-stratiﬁed fracture prevention program andwe had less secondary
LGEA patients, we will continue to monitor its effectiveness and adjustTable 2
Independent risk factors of fracture based on multivariable logistic regression analysis.
Variable tested Odds ratio 95% CI P value
Type of LGEA (Secondary vs. Primary) 1.14 0.25–5.07 0.87
Number of times paralyzed (N3 vs. 1–3) 15.87 1.47–171.23 0.008⁎
Cum. loop diuretic equivalent exposure
(E/kg/days)
1.15 0.78–1.65 0.29
Exposure to non-loop diuretic 2.07 0.43–10.04 0.38
Fracture protocol exposure 0.72 0.14–3.68 0.70
LGEA: Long-Gap Esophageal Atresia; CI: conﬁdence interval.
⁎ Statistically signiﬁcant independent risk factor.the protocol as our population increases. In particular, we must temper
our overall results given (1) the difﬁculty of comparing patients with a
seemingly unequal baseline fracture risk; and, (2) the recognition of the
statistical limitation of interpreting the large conﬁdence interval for the
variable “number of times paralyzed”. Our data does suggest that bone
health and metabolism should be an important clinical topic in the
perioperative management of LGEA patients, which is similar to con-
temporary studies in other high-risk groups; the large number of abso-
lute fractures suggests it to be clinically relevant topic (Khan et al., 2015;
Theintz et al., 1992; Pironi et al., 2002; Done, 2012).
Bone growth and shape is determined by forces that are both in-
trinsic to the tissues themselves, as well as extrinsic physical forces
(Rodriguez et al., 1988; Dunne and Clarren, 1986; Le Veau and
Bernhardt, 1984; Smith, 1981). Mechanical signals modify bone mass
and inﬂuence overall skeletal development, especially in children dur-
ing periods of rather rapid growth, modeling and subsequent remodel-
ing (Rodriguez et al., 1988; Dunne and Clarren, 1986; Le Veau and
Bernhardt, 1984; Smith, 1981; Frost, 1987a,1987b; Ehrlich and Lanyon,
2002). Our population is immobilized during the Foker process in order
to aid with esophageal growth but this may have placed some of these
children at higher risk for fractures given relative immobility and lack of
extrinsic forces. In our study, number of paralysis episodes remained
the only independent risk factor for fracture on multivariate analysis
which suggests that immobilization may play a signiﬁcant role in the
pathogenesis of bone fragility in this population and may also be a sur-
rogate marker for increased disease severity. Relative nutritional deﬁ-
ciencies and diuretic use also likely contribute to poor bone health.
For example, children with intestinal failure may be at a particularly
high risk for metabolic bone disease given factors as malabsorption,
wasting of essential nutrients and minerals, and bacterial overgrowth
(Khan et al., 2015; Klein et al., 1980; Ferrone and Geraci, 2007;
Fewtrell, 2001). Such patients had a fracture risk of 29% but it was not
correlated to previously identiﬁed risk factors (Khan et al., 2015). Sim-
ilar to children with intestinal failure, our cohort did not have an in-
creased risk of fractures with prolonged PN; however, unlike this
cohort, WAZ scores were not predictive of an increased risk of poor
bone homeostasis in our patient population, albeit none of the median
WAZ scores were lower than −2 (Khan et al., 2015; de Onis and
Onyango, 2008).
Use and duration of diuretic have also been associated with an in-
creased risk of fractures (Wei et al., 2012; Dokos et al., 2013; Kann
et al., 2014). Exposure to both loop and non-loop diuretics was
4 S. Bairdain et al. / Bone Reports 3 (2015) 1–4associated with increased risk of fracture on univariate analysis, though
these covariates lost signiﬁcance on the multivariable analysis. Patients
with LGEA undergoing the Foker procedure often require signiﬁcant ex-
posure to both loop and non-loop diuretics; 27% of our patients
sustained a fracture after being exposed concurrently to a non-loop di-
uretic. The concurrent use of both loop and non-loop diuretics may be
confounded by a greater severity of illness and longer period of immo-
bilization. Diuretics were not simply a surrogate marker for disease se-
verity, as there have been multiple studies suggesting the pathological
and pharmacological mechanism for increased fracture risk associated
with the use of diuretics. In the case of loop diuretics, the pathological
mechanism appears to be from the direct wasting of calcium from
bones and the inhibition of laying down new bones, as well as it in-
creases calcium in the urine and cause hypercalciuria, which can be de-
tected by nephrocalcinosis (Schell-Feith et al., 2008). These revelations
have made the LGEA team, as well as associated health care providers
reassess patients who are exposed to both loop and non-loop diuretic
therapy, as they still warrant close monitoring for fracture risk.
Limitations of this studywere its retrospective nature based at a sin-
gle institution with a relatively small cohort size. Still, our described co-
hort is one of the largest LGEA populations that underwent recent Foker
anastomosis attempt, so our results should be generalizable to any cen-
ter that utilizes the Foker process. The introduction of the risk-stratiﬁed
fracture-reduction protocol was not the only variable that distinguished
the pre and post implementation cohorts. There was also a trend to-
wards fewer secondary repairs in the post-protocol cohort, a historically
more complex cohort. We chose to test this variable along with the fol-
lowing other variables to identify independent predictors of fracture:
number of unique episodes of paralysis; cumulative exposure to loop di-
uretics (furosemide equivalents/kg/day); exposure to non-loop di-
uretics; and exposure to fracture protocol. These variables were
chosen given their clinical implications and the manner in which we
could modify with our risk-stratiﬁed protocol. In spite of our concern
that secondary LGEA patients might be a more “severe” cohort, this
was not the case on multivariate analysis and the only variable that
remained signiﬁcant was number of episodes of paralysis.
5. Conclusions and future studies
Number of episodes of paralysis appears to be themain risk factor for
fractures in this cohort of patients with LGEA. In the choice of diuretic
therapy, exposure as to both loop and non-loop diuretics concurrently
had an increased fracture risk and these patients still warrant close
monitoring. At our institution, these data have initiated multi-
disciplinary discussions focusing on fracture prevention, leading to the
development of a consensus-driven approach. Short-term results
show that the incidence of symptomatic fractures has decreased from
48% to 21% following the implementation of a standardized protocol
in this series of LGEA patients. We will continue to monitor the safety
and effectiveness of this approach.
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